What happened this week? An award for Kymab, disappointment for Crowdfunding and some Wasps to save us!

Biotechnology Europe

Monday: A report said that the total value of crowdfunded Biotech projects from within the EU since 2010 is €23M.


Tuesday: Researchers from University of Leeds unraveled the mechanism of cancer-targeting effects of Wasp venom.


Wednesday: Kymab has been listed in the Sunday Times Tech Track ‘One’s to Watch’ 2015 just this month!

Thursday: CureVac just announced the opening of its subsidiary in Boston and a research collaboration to develop a mRNA-based HIV treatment.

Friday: Cambridge biotech leader Abcam and Horizon Discovery finally came together to partner up on antibody research

Explore other topics: AbcamCurevacHorizon DiscoveryKymab

Newsletter Signup - Under Article / In Page

"*" indicates required fields

Subscribe to our newsletter to get the latest biotech news!

This field is for validation purposes and should be left unchanged.

Suggested Articles

Show More